Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by jopatcloon Oct 18, 2024 9:11am
59 Views
Post# 36271303

RE:RE:What's up? Not the share price.

RE:RE:What's up? Not the share price.
jopatclo wrote: GranhamB Relax the negatives vulture ...just a pennie flipper that came out in the last hour to go into another stock which caused this drop and scared the small investors.Mec negative why do you spend so much time here if you hate it so much? Is it all for the “I-told-you-so’s”? Is it some sort of masochism? Positif Insiders buy on the one market for one reason, they think its going up Insiders know! “I-told-you-so’s”

good news and comment Now That V4.0 est ok pour le Canada   I think we will have news soon. November is coming tic..tac..
Europe V4.0 and Sales at any time now Insiders know!$$$ 
The BEST automation and analysis of the PLANET GEN3EHO see.
 (Remember  On website Ascend https://ascendcv.com/   Clic On integration see
Ventripoint - The integration of Gen3Echo with Ventripoint’s innovative application of AI to echocardiography)
 I thing news comming   remember post Hugh  #vpt
* 5. Our staff and associates are energized by interactions with customers and we have many top cardiac centers looking at the VMS+.  Announcements from these revered hospitals will be forthcoming.
*6. The recent grant of a license from Health Canada for VMS+4.0 will now allow us to market this revolutionary advancement in Canada and we have already begun that process. Maybe ? $$$ (=2 Pediatrics Hospital for Sick Children Toronto Canada Oncology, Orthopedics, Neurosurgery) 
 The Company has submitted an application to the US-FDA and soon will submit for European CE Mark.
& Announcements from these revered hospitals will be forthcoming.  

 
0
from #vpt, 
 
@Ducati_848 Putting this 1000 piece puzzle together, 1 piece at a time. Time & patience. Looks like we’re on the right path.
 
1
from #vpt, 
 
@Ducati_848 I’m pretty confident the debenture financing will close upon FDA approval of 4.0.
 
@yudi Bonjour the negatives Positif Insiders buy on the one market for one reason, they think its going up Insiders know! “I-told-you-so’s”
 
0
from #vpt, 
 
@Ducati_848 Putting this 1000 piece puzzle together, 1 piece at a time. Time & patience. Looks like we’re on the right path.
 
1
from #vpt, 
 
@Ducati_848 I’m pretty confident the debenture financing will close upon FDA approval of 4.0.

<< Previous
Bullboard Posts
Next >>